Morgan Stanley Boston Scientific Corp Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in Boston Scientific Corp stock. As of the latest transaction made, Morgan Stanley holds 20,480,775 shares of BSX stock, worth $2.16 Billion. This represents 0.13% of its overall portfolio holdings.

Number of Shares

20,480,775

Previous 19,075,161 7.37%

Holding current value

$2.16 Billion

Previous $1.6 Billion 14.44%

% of portfolio

0.13%

Previous 0.12%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$83.62 - $91.5 $118 Million - $129 Million	1,405,614 Added 7.37%	20,480,775 $1.83 Billion
Q3 2024 Nov 14, 2024	BUY	$72.96 - $84.0 $10.9 Million - $12.5 Million	149,267 Added 0.79%	19,075,161 $1.6 Billion
Q2 2024 Oct 17, 2024	BUY	$67.33 - $77.71 $64.7 Million - $74.7 Million	961,111 Added 5.35%	18,925,894 $1.46 Billion
Q2 2024 Aug 14, 2024	BUY	$67.33 - $77.71 $64.7 Million - $74.7 Million	961,111 Added 5.35%	18,925,894 $1.46 Billion
Q1 2024 Oct 17, 2024	SELL	$57.6 - $68.62 $55.4 Million - $66 Million	-961,111 Reduced 5.08%	17,964,783 $1.23 Billion
Q1 2024 Aug 16, 2024	SELL	$57.6 - $68.62 $45.9 Million - $54.7 Million	-796,798 Reduced 4.25%	17,964,783 $1.23 Billion
Q1 2024 May 15, 2024	SELL	$57.6 - $68.62 $45.9 Million - $54.7 Million	-796,798 Reduced 4.25%	17,964,783 $1.23 Billion
Q4 2023 Aug 16, 2024	SELL	$48.64 - $57.81 $7.99 Million - $9.5 Million	-164,313 Reduced 0.87%	18,761,581 $1.08 Billion
Q4 2023 Feb 13, 2024	SELL	$48.64 - $57.81 $119 Million - $141 Million	-2,438,758 Reduced 11.5%	18,761,581 $1.08 Billion
Q3 2023 Nov 15, 2023	BUY	$50.19 - $54.68 $24.2 Million - $26.3 Million	481,891 Added 2.33%	21,200,339 $1.12 Billion
Q2 2023 Aug 14, 2023	BUY	$49.72 - $54.64 $19.2 Million - $21.1 Million	386,987 Added 1.9%	20,718,448 $1.12 Billion
Q1 2023 May 15, 2023	BUY	$45.09 - $50.03 $49 Million - $54.4 Million	1,086,407 Added 5.65%	20,331,461 $1.02 Billion
Q4 2022 Feb 14, 2023	BUY	$39.56 - $47.22 $271 Million - $323 Million	6,842,597 Added 55.17%	19,245,054 $891 Million
Q3 2022 Nov 14, 2022	BUY	$36.71 - $109.66 $56.4 Million - $169 Million	1,537,156 Added 14.15%	12,402,457 $480 Million
Q2 2022 Oct 27, 2022	BUY	$35.24 - $47.1 $216 Million - $289 Million	6,142,145 Added 130.04%	10,865,301 $405 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $216 Million - $289 Million	6,142,145 Added 130.04%	10,865,301 $405 Million
Q1 2022 Oct 27, 2022	SELL	$40.9 - $45.1 $251 Million - $277 Million	-6,142,145 Reduced 56.53%	4,723,156 $209 Million
Q1 2022 May 13, 2022	SELL	$40.9 - $45.1 $5.92 Million - $6.52 Million	-144,627 Reduced 2.97%	4,723,156 $209 Million
Q4 2021 Feb 14, 2022	BUY	$38.07 - $44.87 $3.53 Million - $4.16 Million	92,629 Added 1.94%	4,867,783 $207 Million
Q3 2021 Nov 15, 2021	BUY	$41.23 - $45.88 $197 Million - $219 Million	4,775,154 New	4,775,154 $207 Million

Others Institutions Holding BSX

# of Institutions

1,656

Shares Held

1.22B

Call Options Held

8.76M

Put Options Held

9.42M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $151B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account